COLLPLANT BIOTECH. IS-01 Net Asset Quality Index
COLLPLANT BIOTECH. IS-01 net asset quality index. COLLPLANT BIOTECH. IS-01 (CPT) has a Net Asset Quality Index of 53.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €9.18 Million minus total liabilities of €4.30 Million yields net assets of €4.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. See CPT net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of COLLPLANT BIOTECH. IS-01 (2021–2025)
Net asset quality index of COLLPLANT BIOTECH. IS-01 from 2021 to 2025. This chart shows how COLLPLANT BIOTECH. IS-01's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 53.2%, representing net assets of €4.89 Million against total assets of €9.18 Million EUR. Check COLLPLANT BIOTECH. IS-01 (CPT) tangible equity ratio to evaluate the tangible quality of the company's equity base.
COLLPLANT BIOTECH. IS-01 Net Asset Quality Index by Year (2021–2025)
COLLPLANT BIOTECH. IS-01 net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for COLLPLANT BIOTECH. IS-01 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CPT stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 56.4% | €6.08 Million | €10.79 Million | €4.70 Million | ▼ -15.6 pp |
| 2024 | 72.0% | €13.46 Million | €18.71 Million | €5.25 Million | ▼ -11.1 pp |
| 2023 | 83.0% | €28.34 Million | €34.13 Million | €5.79 Million | ▼ -2.4 pp |
| 2022 | 85.5% | €32.28 Million | €37.77 Million | €5.49 Million | ▼ -2.6 pp |
| 2021 | 88.1% | €45.12 Million | €51.22 Million | €6.10 Million | — |